Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial.
Rossen Mihaylov HazarbassanovN G T Queiroz-HazarbassanovJ N BarrosJ A P GomesPublished in: Journal of ophthalmology (2018)
Op was superior to FT in regard to pain, osmolarity, TBUT, and Schirmer 1. Osmoprotectant solutes, such as L-carnitine, could attenuate inflammation and secondary DED. Osmoprotective lubricants can be effectively applied for the prevention of refractive surgery-related dry eye symptoms and signs.
Keyphrases
- minimally invasive
- coronary artery bypass
- study protocol
- clinical trial
- phase iii
- oxidative stress
- chronic pain
- double blind
- phase ii
- surgical site infection
- sleep quality
- diabetic rats
- randomized controlled trial
- high glucose
- pain management
- drug induced
- neuropathic pain
- spinal cord injury
- open label
- coronary artery disease
- atrial fibrillation
- stress induced
- cataract surgery